"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antivirals
- Antiviral Drugs
- Drugs, Antiviral
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 2 | 3 |
| 1995 | 9 | 2 | 11 |
| 1996 | 10 | 3 | 13 |
| 1997 | 8 | 4 | 12 |
| 1998 | 9 | 2 | 11 |
| 1999 | 9 | 3 | 12 |
| 2000 | 2 | 3 | 5 |
| 2001 | 7 | 5 | 12 |
| 2002 | 5 | 6 | 11 |
| 2003 | 6 | 5 | 11 |
| 2004 | 8 | 3 | 11 |
| 2005 | 6 | 3 | 9 |
| 2006 | 14 | 5 | 19 |
| 2007 | 13 | 7 | 20 |
| 2008 | 5 | 5 | 10 |
| 2009 | 6 | 6 | 12 |
| 2010 | 9 | 3 | 12 |
| 2011 | 17 | 4 | 21 |
| 2012 | 8 | 2 | 10 |
| 2013 | 7 | 4 | 11 |
| 2014 | 18 | 1 | 19 |
| 2015 | 14 | 4 | 18 |
| 2016 | 10 | 1 | 11 |
| 2017 | 7 | 5 | 12 |
| 2018 | 4 | 3 | 7 |
| 2019 | 9 | 6 | 15 |
| 2020 | 7 | 10 | 17 |
| 2021 | 10 | 11 | 21 |
| 2022 | 1 | 4 | 5 |
| 2023 | 1 | 6 | 7 |
| 2024 | 4 | 4 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review. JAMA. 2024 Nov 19; 332(19):1652-1662.
-
Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma. JAMA. 2024 09 24; 332(12):1013-1014.
-
A drug repurposing screen identifies decitabine as an HSV-1 antiviral. Microbiol Spectr. 2024 Nov 05; 12(11):e0175424.
-
Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19. Clin Infect Dis. 2024 Aug 16; 79(2):354-363.
-
Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee. Transpl Infect Dis. 2024 Nov; 26 Suppl 1:e14305.
-
Ginkgolic acid inhibits orthopneumo- and metapneumo- virus infectivity. Sci Rep. 2024 04 08; 14(1):8230.
-
Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP. Nat Commun. 2024 Mar 20; 15(1):2476.
-
Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania. J Antimicrob Chemother. 2024 01 03; 79(1):36-45.
-
Twelve-month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients. Transpl Infect Dis. 2024 Feb; 26(1):e14213.
-
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer. Sci Adv. 2023 10 13; 9(41):eade3816.